Psilocybin Study Shows Early Promise for Parkinson’s Patients
A new clinical trial has found that psilocybin may help ease both motor and mood symptoms in people living with Parkinson’s disease.
Read More
Ketamine Study Yields Surprising Findings That Could Change Depression Treatment
A new study from Stanford University has uncovered unexpected results about ketamine’s role in treating depression.
Read More
Spravato Nasal Spray to Be Subsidized in Australia for Treatment Resistant Depression
The Australian government has announced that Spravato will be added to the Pharmaceutical Benefits Scheme starting July 1.
Read More
VA Secretary Signals Openness to Psychedelic and Alternative Treatments
The VA will explore new treatment options, including psychedelic therapy, according to recent comments from VA Secretary Doug Collins.
Read More
Everyone’s on Mushrooms: Psilocybin Use Soars Amid Legal and Cultural Shifts
Psilocybin use in the United States has surged dramatically since 2019, marking a turning point in both public perception and behavior
Read More
Single Dose of Psychedelics May Boost Memory, Study Finds
A single dose of a novel psychedelic compound significantly improved memory, according to a new study from the University of Michigan.
Read More
Texas Lawmakers Consider New Pathways for Psychedelic-Assisted Therapy
Texas lawmakers are advancing a series of bills that could significantly change how residents access psychedelic therapy.
Read More
J&J’s Spravato On Track to Become a $3.5B Drug By 2028
If the current trajectory holds, J&J's Spravato could reach up to 3.5 billion dollars in annual sales by 2028.
Read More
New Mexico Passes First State Legislature-Driven Psilocybin Access Act
New Mexico became the third state to provide legal access to psilocybin. But the Land of Enchantment is doing it a little differently.
Read More
Colorado Just licensed Its First Psilocybin Healing Center
Psychedelic-assisted therapy is advancing in Colorado with the state's first licensed healing center set to open by late April.
Read More